Please select the option that best describes you:

Do you give an etoposide-based regimen/more aggressive therapy for lymphoma-associated HLH, such as da-EPOCH-R over R-CHOP?  

What about changing standard regimens for TCL with HLH?



Answer from: Medical Oncologist at Academic Institution
Sign in or Register to read more